Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Cultured meat firm resurrects woolly mammoth in lab-grown meatball

From TechCrunch

By Paul Sawers

March 28, 2023

Cultured meat firm resurrects woolly mammoth in lab-grown meatball

Truth, as the saying goes, is often stranger than fiction. The very notion of resurrecting the long-extinct woolly mammoth was the stuff of fantasy not that long ago, but scientists are already working on ways to achieve something close to that, using DNA from soft-tissue in frozen mammoth remains and meshing it with that of a modern-day elephant.

But while such “de-extinction” projects may or may not ultimately succeed, one company is already laying claim to having produced the first meat product made from mammoth DNA.

Vow, an Australian cultivated food company that creates meat in a laboratory setting from animal cells, says that it has used advanced molecular engineering to resurrect the woolly mammoth in meatball form, by combining original mammoth DNA with fragments of an African elephant’s DNA.

Mammoth meatball Image Credits: Aico Lind

James Ryall, Vow’s chief science officer, said that the company first identified the mammoth myoglobi , a protein that is key to giving meat its color and taste, and then used publicly available data to identify the DNA sequence in mammoths.

“We filled in any gaps in the DNA sequence of this mammoth myoglobin gene, by using the genome of the African elephant, the mammoth’s closest living relative [editor’s note: it’s actually the Asian elephant that is the mammoth’s closest living relative],” Ryall said in a video announcing the mammoth meatball. “We inserted the mammoth myoglobin gene into our cells using a very low-current and high-voltage charge. Then we continued to grow and multiply these cells just as would occur in a mammoth thousands of years ago. And the amazing thing about this is that not a single animal needed to die to produce the mammoth meatball.”

Cultivated

There’s little question that cultivated meat is coming, evidenced by the countless companies raising vast swathes of venture capital funding to produce meat and fish in a lab from animal cells, as well as the fact that companies are now starting to receiving the blessings of regulators such as the U.S. Food and Drug Administration (FDA). But while pork sausages and seafood make sense insofar as they are food that people are familiar with, Vow — which closed a $49.2 million round of funding just a few months ago — is clearly upping the ante with its foray into the world of extinct animals.

It’s worth acknowledging that there is a sizeable element of marketing magicianship to this announcement. The very concept was devised by communications agency and WPP-subsidiary Wunderman Thompso , which tells us something about the intent here — this is very much a promotional campaign for Vow. But at the same time, it’s also a promotional campaign for cultured meat in general, and the role it could play in creating a sustainable protein source that doesn’t involve killing animals. By some estimations, around 60% of greenhouse gas emissions from food production emanate from animal-based foods, double that of plant-based equivalents.

“The goal behind creating the mammoth meatball was really about starting that discussion around food, and what that decision to eat meat really means to the world at large, by bringing an extinct protein back to life,” Ryall said.

This isn’t the first time a scientists have created edibles from extinct animals. Back in 2018, a VC-backed Silicon Valley startup called Geltor made gummies using protei from a mastodon, another distant relative of elephants. However, in this latest instance, it’s believed that nobody has actually tasted one of the mammoth meatballs. Speaking to the Guardian newspaper, Professor Ernst Wolvetang, from the Australian Institute for Bioengineering at the University of Queensland which worked with Vow in this project, suggested that it’s probably not safe to try the meatball just now, even if regulators permitted it.

“We haven’t seen this protein for thousands of years,” Wolvetang said. “So we have no idea how our immune system would react when we eat it. But if we did it again, we could certainly do it in a way that would make it more palatable to regulatory bodies.”

The mammoth meatball is set to be officially unveiled at Nemo Science Museum in the Netherlands today.

Cultured meat firm resurrects woolly mammoth in lab-grown meatball by Paul Sawers originally published on TechCrunch

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

Cultured meat startup Higher Steaks nabs $30M and rebrands as Uncommon

Cultured meat startup Higher Steaks nabs $30M and rebrands as Uncommon

U.K.-based cultivated meat startup Higher Steaks has raised $30 million in a Series A round of funding and revealed that it’s changing its name to Uncommon. Founded out of Cambridge in 2017, Uncommon is one of countless companies pushing to make cultured “lab-grown” meat a reality in kitchens and restaurants around the globe, covering everything […]

Jun 8, 2023

This week in foodtech: Cultivated meat is still a sizzling topic

This week in foodtech: Cultivated meat is still a sizzling topic

If you’re adventurous with your food, or just like to keep up with the fast-moving foodtech industry, here’s a roundup of this week’s stories and some notable news we weren’t able to cover.

Jun 10, 2023

Mission Barns is betting that animal-free pork fat will make artificial meat delicious

Mission Barns is betting that animal-free pork fat will make artificial meat delicious

It’s the first such product to reach the market, and it could unlock a host of fattened-up meat alternatives.

Jul 24, 2025

Omeat emerges from stealth with beefy tech approach to cultivated meat growth media

Omeat emerges from stealth with beefy tech approach to cultivated meat growth media

Omeat's process uses regenerative factors extracted humanely from cow plasma to make growth media to create beef, pork, chicken or fish.

Jun 22, 2023

Most Recent

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Jul 20, 2026

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

Natural raises $30M to reinvent payments for AI agents — and take on Stripe

The one-year-old startup aims to reinvent financial architecture for autonomous AI transactions.

Jul 20, 2026

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

Inference startup Infinity raises $15M from Touring Capital, OpenAI and Anthropic researchers

AI infrastructure company Infinity announced Monday a $15 million raise at a $100 million valuation from investors including Touring Capital, Principal VC, and researchers from companies such as OpenAI and Anthropic.

Jul 20, 2026

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

StrictlyVC returns to New York City September 10 to celebrate a huge year for the city’s startup community

For the first time since 2024, StrictlyVC is coming back to New York City — and we're bringing the kind of access you’d expect from an under-wraps event to the whole startup, VC, and dealmaking community.

Jul 20, 2026

Similar Posts

Cultured meat startup Higher Steaks nabs $30M and rebrands as Uncommon

Cultured meat startup Higher Steaks nabs $30M and rebrands as Uncommon

U.K.-based cultivated meat startup Higher Steaks has raised $30 million in a Series A round of funding and revealed that it’s changing its name to Uncommon. Founded out of Cambridge in 2017, Uncommon is one of countless companies pushing to make cultured “lab-grown” meat a reality in kitchens and restaurants around the globe, covering everything […]

Jun 8, 2023

This week in foodtech: Cultivated meat is still a sizzling topic

This week in foodtech: Cultivated meat is still a sizzling topic

If you’re adventurous with your food, or just like to keep up with the fast-moving foodtech industry, here’s a roundup of this week’s stories and some notable news we weren’t able to cover.

Jun 10, 2023

Mission Barns is betting that animal-free pork fat will make artificial meat delicious

Mission Barns is betting that animal-free pork fat will make artificial meat delicious

It’s the first such product to reach the market, and it could unlock a host of fattened-up meat alternatives.

Jul 24, 2025

Omeat emerges from stealth with beefy tech approach to cultivated meat growth media

Omeat emerges from stealth with beefy tech approach to cultivated meat growth media

Omeat's process uses regenerative factors extracted humanely from cow plasma to make growth media to create beef, pork, chicken or fish.

Jun 22, 2023